Table 3 Demographic and clinical characteristics of the study population (cognitive cohort)
From: ESRD-associated immune phenotype depends on dialysis modality and iron status: clinical implications
PD n = 37 | HD n = 47 | p | |
|---|---|---|---|
Age (years) | 67 ± 19 | 68 ± 14 | 0.770 |
Gender (% male) | 75% | 68% | 0.626 |
Dialysis duration (months) | 33 ± 20 | 63 ± 123 | 0.168 |
Diabetes (%) | 36 | 34 | 0.900 |
BMI | 27.1 ± 4.7 | 26.7 ± 4.7 | 0.703 |
25OH D3 (ng/ml) | 24 + 9 | 30 + 11 | 0.018 |
PTH (pg/ml) | 393 + 313 | 401 + 253 | 0.961 |
Ferritin (ng/ml) | 277 ± 277 | 481 ± 396 | 0.007 |
Albumin (g/l) | 32 ± 4 | 34 ± 3 | 0.049 |